Blog
-
-
Contentious report suggests safety net hospitals leveraging discounts to pocket strong gains from cancer drugs
-
Amgen to advance KRAS drug combination after improved results in colon cancer
-
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop
-
The Hospital Price Transparency Paradox
-
CMS requiring insurers to submit data on air ambulance services, broker compensation
-
Merck, Amgen adopt double-digit price hikes in test to Big Pharma’s unofficial annual limits: analyst
-
Zimmer Biomet, Canary Medical land FDA de novo clearance for sensor-equipped ‘smart’ knee implant
-
Abbott nets US approval for its Amplatzer Amulet heart implant to help cut down afib stroke risks
-
Roche sets bar in early lymphoma treatment with Polivy study results